Effects of leukocyte depletion on cardiopulmonary protection and inflammation after valve surgery

International Journal of Artificial Organs

Volumn 33, Issue 11, 2010, Pages 812-818

  Zhang, Xiaohua ^a   Zhou, Chengbin ^a   Zhuang, Jian ^a   Xiao, Xuejun ^a   Zheng, Shaoyi ^a   Xiong, Weiping ^a   Wang, Wenxian ^a   Wu, Ruobin ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Heart valve; Inflammatory mediators; Leukocytes; Lung; Myocardial protection

Indexed keywords

BIOLOGICAL ORGANS; BLOOD VESSELS; BODY FLUIDS;

AORTIC VALVES; CONTROL GROUPS; HEART VALVES; INFLAMMATORY MEDIATORS; INFLAMMATORY RESPONSE; LEUCOCYTES; MITRAL VALVES; MYOCARDIAL PROTECTION; SERUM LEVELS; VALVE REPLACEMENT;

SURGERY;

INTERLEUKIN 6; INTERLEUKIN 8; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA CLAMPING; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPULMONARY BYPASS; CELL SEPARATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART INJURY; HEART PROTECTION; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NEUTROPHIL; NEUTROPHIL COUNT; OXYGENATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL;

EID: 78650849694     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003301106     Document Type: Article

References (22)

1. Hachida M, Hanayama N, Okamura T, et al. The role of leucocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 1995; 41: M291-4.
2. Littt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Circulation 1989; 80: 1816-27.
3. Galinanes M, Lawson CS, Ferrari R, Limb GA, Derias NW, Hearse DJ. Early and late effects of leukopenic reperfusion on the recovery of cardiac contractile function. Circulation 1993; 88: 673-83.
4. Sawa Y, Taniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation 1996; 93: 1640-6.
5. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klovenkorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg 2000; 120: 642-50.
6. Warner KG, Khuri SF, Kloner RA. Structural and metabolic correlates of cell injury in the hypertrophied myocardium during valve replacement. J Thorac Cardiovasc Surg 1987; 93: 741-54.
7. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 873-7.
8. Gu YJ, de Vrues AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996; 112: 494-500.
9. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 2004; 78: 1339-44.
10. Kirklin JK, Westaby S, Blackstone EH, Kirlin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
11. Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 1988; 123: 1496-1501.
12. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion of rat lung. Am J Pathol 1997; 150: 1773-84.
13. Johnson D, Thomson D, Hurst T, et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg 1994; 107: 1193-202.
14. te Velthuis H, Jansen PGM, Oudemans-van Straaten HM, Sturk A, Eijsman L, Wildevuur CRH. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by rumor necrosis factor. J Thorac Cardiovasc Surg 1995; 110: 1663-9.
15. Partrick DA, Moore FA, Moore EE, Biffl WL, Sauaia A, Barnett CC Jr. The inflammatory profile of interleukin-6, interleukin-8 and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996; 172: 425-31.
16. Ilmakunnas M, Pesonen EJ, Ahonen J, Rämö J, Sittonen S, Repo H. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 129: 851-9.
17. Baksaas ST, Flom-Halvorsen HI, Ovrum E, et al. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion 1999;14: 107-17.
18. Koskenkari JK, Rimpilainen J, Ohman H, et al. Leukocyte filter enhances neutrophil activation during combined aortic valve and coronary artery bypass surgery. Heart Surg Forum 2006; 9: E693-9.
19. Whitaker DC, Newman SP, Stygall J, Hope-Wynne C, Harrison MJG, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25: 267-74.
20. Patel AN, Sutton SW, Livingston S, et al. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg 2003; 186: 636-9, discussion 639-40.
21. Sahlman A, Ahonen J, Salo JA, Ramo OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand 2001; 45: 558-63.
22. Lust RM, Bode AP, yang L, Hodges W, Chitwood R Jr. In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial. ASAIO J 1996; 42: M819-22.